quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:05:51·444d
SECFiling
Omega Therapeutics Inc. logo

Omega Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Leadership Update, Other Events

OMGA· Omega Therapeutics Inc.
Health Care
Original source

Companies

  • OMGA
    Omega Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Nov 15UpdateRaymond James-
  • Jun 18UpdateRaymond James$12.00
  • May 25UpdateJefferies$15.00
  • Dec 8UpdateH.C. Wainwright$11.00
  • Sep 23UpdateChardan Capital Markets$12.00
  • Aug 24UpdateWedbush$36.00

Related

  • SEC394d
    SEC Form EFFECT filed by Omega Therapeutics Inc.
  • SEC398d
    SEC Form POS AM filed by Omega Therapeutics Inc.
  • SEC398d
    SEC Form S-8 POS filed by Omega Therapeutics Inc.
  • SEC399d
    SEC Form 25 filed by Omega Therapeutics Inc.
  • SEC412d
    Amendment: SEC Form SCHEDULE 13G/A filed by Omega Therapeutics Inc.
  • SEC423d
    SEC Form 8-K filed by Omega Therapeutics Inc.
  • SEC433d
    Omega Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation
  • SEC442d
    Amendment: SEC Form SCHEDULE 13D/A filed by Omega Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022